IMGT Corporation Limited Logo

IMGT Corporation Limited

Develops a drug delivery platform using focused ultrasound and nanotechnology.

456570 | KO

Overview

Corporate Details

ISIN(s):
KR7456570001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 돌마로 172, 성남시

Description

IMGT Corporation Limited is a clinical-stage biotechnology company that develops a proprietary drug delivery platform for intractable diseases. The company's core technology integrates focused ultrasound with nanotechnology to create an image-guided therapy system. This platform is designed to enhance the targeted delivery of gene therapies, nanomedicines, and other therapeutic agents directly to diseased tissues. By leveraging the synergistic effects of ultrasound and nanoparticles, IMGT aims to improve treatment efficacy and precision, particularly in oncology. The company is actively advancing its solutions through clinical trials for applications such as pancreatic cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-22 00:00
임상시험단계진입ㆍ종료(자율공시)(간암치료용 항암약물 나노전달체(의료기기) 국내 임상시험계획(IDE) 승인)
Korean 10.1 KB
2023-08-04 00:00
임상시험단계진입ㆍ종료(자율공시)(진행성/전이성 고형암 환자 대상 의약품의 제1상 임상시험계획(IND) 승인)
Korean 9.9 KB
2023-07-25 00:00
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2023-07-25 00:00
주식등의대량보유상황보고서(약식)
Korean 84.1 KB
2023-07-21 00:00
사업보고서 (2022.12)
Korean 373.1 KB
2023-04-11 00:00
감사보고서 (2022.12)
Korean 373.1 KB
2022-04-08 00:00
감사보고서 (2021.12)
Korean 425.6 KB

Automate Your Workflow. Get a real-time feed of all IMGT Corporation Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMGT Corporation Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMGT Corporation Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Develops a protein-based bone graft substitute for spinal fusion procedures.
United States of America
BBLG
Bonyf N.V. Logo
Develops medical devices for oral, dental, orthodontic, and dermatological care.
Belgium
MLBON
Boryung Corporation Logo
A healthcare company developing pharmaceuticals and investing in health sector innovation.
South Korea
003850
Bosnalijek d.d. Sarajevo Logo
Develops, manufactures, and exports a wide range of pharmaceutical products.
Bosnia and Herzegovina
BSNL
Boule Diagnostics Logo
Provider of hematology systems for decentralized human and veterinary markets.
Sweden
BOUL
Boundless Bio, Inc. Logo
Clinical-stage oncology company targeting ecDNA in oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma developing inhibitors for genetically driven cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Develops selective serotonin agonists for neurological and psychiatric disorders.
United States of America
DRUG
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
Japan
4594

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.